High expression of CTDNEP1 gene linked to poorer kidney cancer survival
Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for about 90% of kidney…
New scanning method detects basal cell carcinoma early using AI
Researchers at FAU combine optical diagnosis method with AI-assisted image recognition. Until now, diagnosing skin tumors has relied…
New spin-out launches technology to revolutionize hormone disorder diagnosis
The University of Birmingham and Imperial College London have announced the launch of Intelligent Mass Spec Solutions Ltd…
Like your tea or coffee very hot? A study of nearly 1 million adults found a striking cancer link
A study of nearly one million UK adults examines how drinking temperature and daily consumption relate to two…
New integrated framework advances precision surgery for liver cancer
Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. Despite…
Computational pipeline uncovers subtype specific targets for cervical cancer
A new study presents a multi-layered strategy for identifying cell-surface targets that could help guide more precise antibody-drug…
Combination therapy overcomes ferroptosis resistance in β-catenin-mutant hepatocellular carcinoma
Background and aims The aberrant activation of the mTOR pathway and its crosstalk with other signaling cascades represent…
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
Daily tomatoes lowered a key marker of liver fat in MASLD trial
A six-week tomato-rich diet outperformed a tomato-free diet on an important marker of hepatic steatosis, pointing to a…
Occult hepatitis B mutations drive liver cancer growth via Akt mTOR pathway
Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar of…
Integrating gene signatures and multi omics improves liver cancer treatment
Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers. Multi‑omics and liquid biopsy…
Tumor microenvironment drives drug resistance in lung cancer subtypes
A study by the University of Barcelona has discovered why the two main types of lung cancer –…